Published in Int J Radiat Oncol Biol Phys on March 01, 2009
Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol (2010) 4.04
Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet (2010) 2.20
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas. Nucl Med Biol (2010) 1.08
Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Arch (2010) 1.02
Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int (2013) 0.97
Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. Oncogene (2013) 0.91
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res (2016) 0.80
Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival. Virchows Arch (2015) 0.77
Are podoplanin and ezrin involved in the invasion process of the ameloblastomas? Eur J Histochem (2015) 0.76
Pharmacogenomics and cancer stem cells: a changing landscape? Trends Pharmacol Sci (2011) 0.76
Role of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study. J Oral Biol Craniofac Res (2016) 0.75
Overexpression and lack of copy number variation in the BMI-1 gene in human glioma. Oncol Lett (2015) 0.75
Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer. Clin Oral Investig (2016) 0.75
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg (2004) 1.72
Heterogeneous expression and regulation of CD40 in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol (2003) 1.40
Assessment of gene transcription demonstrates connection with the clinical course of idiopathic interstitial pneumonia. Respiration (2008) 1.40
Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun (2003) 1.28
VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery (2006) 1.24
Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res (2004) 1.23
Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol (2005) 1.21
Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock (2004) 1.20
Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis (2006) 1.15
Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells. Wien Klin Wochenschr (2008) 1.06
Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J Cutan Pathol (2007) 1.02
Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol (2008) 1.01
Speech and music perception with the new fine structure speech coding strategy: preliminary results. Acta Otolaryngol (2007) 0.97
Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol (2003) 0.97
Expression of the Sonic hedgehog pathway in squamous cell carcinoma of the skin and the mucosa of the head and neck. Head Neck (2011) 0.96
Dysphagia due to a large schwannoma of the oropharynx: case report and review of the literature. Arch Otolaryngol Head Neck Surg (2002) 0.95
Economic concerns about global healthcare in lung, head and neck cancer: meeting the economic challenge of predictive, preventive and personalized medicine. EPMA J (2010) 0.94
Neoplastic stem cells: a novel therapeutic target in clinical oncology. Cancer (2006) 0.94
The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine. EPMA J (2010) 0.93
Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome. J Pediatr (2003) 0.93
Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla. Eur J Nucl Med Mol Imaging (2011) 0.92
HPV infection and p16 expression in carcinomas of the minor salivary glands. Eur Arch Otorhinolaryngol (2011) 0.92
Merkel cell carcinoma: the past, the present, and the future. J Skin Cancer (2013) 0.92
Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia. Eur J Haematol (2006) 0.91
Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun (2003) 0.91
A new blended learning concept for medical students in otolaryngology. Arch Otolaryngol Head Neck Surg (2012) 0.91
Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck. Oncol Rep (2008) 0.90
BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma. Pathol Oncol Res (2008) 0.90
Van Der Woude syndrome: variable penetrance of a novel mutation (p.Arg 84Gly) of the IRF6 gene in a Turkish family. Int J Mol Med (2005) 0.90
Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity. Microcirculation (2004) 0.90
Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas. Mod Pathol (2006) 0.90
Expression of hedgehog signaling molecules in Merkel cell carcinoma. Head Neck (2010) 0.90
Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol (2010) 0.89
Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wien Klin Wochenschr (2011) 0.89
Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol (2005) 0.88
Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Clin Cancer Res (2005) 0.88
Imaging in patients with merkel cell carcinoma. J Skin Cancer (2013) 0.88
Volumetric changes of the anterolateral thigh free flap following adjuvant radiotherapy in total parotidectomy reconstruction. Laryngoscope (2012) 0.88
Transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma of the parotid gland is independent of p53 mutations. J Surg Oncol (2010) 0.87
Autophagy in the thymic epithelium is dispensable for the development of self-tolerance in a novel mouse model. PLoS One (2012) 0.86
P53 mutation is a rare event in Merkel cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol (2011) 0.86
Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation. Histochem Cell Biol (2011) 0.86
The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation. Histochem Cell Biol (2012) 0.86
Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod. Int J Dermatol (2003) 0.85
Correlation of β-catenin, but not PIN1 and cyclin D1, overexpression with disease-free and overall survival in patients with cancer of the parotid gland. Head Neck (2014) 0.85
Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression. Mod Pathol (2010) 0.84
Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane. Strahlenther Onkol (2011) 0.84
Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer (2013) 0.83
Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Head Neck (2003) 0.83
Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res (2008) 0.83
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochem Pharmacol (2006) 0.83
Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients. J Surg Oncol (2008) 0.83
Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines. Oncol Rep (2005) 0.83
Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems. Strahlenther Onkol (2015) 0.82
Effects of epidermal growth factor and keratinocyte growth factor on the growth of oropharyngeal keratinocytes in coculture with autologous fibroblasts in a three-dimensional matrix. Cells Tissues Organs (2006) 0.82
ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study. BMC Cancer (2012) 0.82
7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2009) 0.81
Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience. Eur Arch Otorhinolaryngol (2014) 0.81
Significant correlation of peptidyl-prolyl isomerase overexpression in Merkel cell carcinoma with overall survival of patients. Head Neck (2010) 0.81